Genetic association of primary nonresponse to anti-TNFα therapy in patients with inflammatory bowel disease

被引:3
作者
De, Tanima [1 ]
Zhang, Honghong [1 ]
Alarcon, Cristina [1 ]
Lec, Bianca [1 ]
Avitia, Juan [1 ]
Smithberger, Erin [2 ]
Chen, Chuyu [1 ]
Horvath, Minnie [1 ]
Kwan, Sara [3 ]
Young, Mary [3 ]
Adhikari, Sarbani [3 ]
Kwon, John [2 ]
Pacheco, Jennifer [1 ]
Jarvik, Gail [4 ,5 ]
Wei, Wei-Qi [6 ]
Mentch, Frank [7 ]
Hakonarson, Hakon [7 ,8 ]
Sleiman, Patrick [7 ,8 ]
Gordon, Adam [1 ]
Harley, John [9 ,10 ]
Linneman, Jim [11 ]
Hebbring, Scott [12 ]
Parisiadou, Loukia [1 ]
Perera, Minoli A. [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA
[2] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27515 USA
[3] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA
[4] Univ Washington, Dept Med Med Genet, Med Ctr, Seattle, WA 98195 USA
[5] Univ Washington, Med Ctr, Dept Genome Sci, Seattle, WA 98195 USA
[6] Vanderbilt Univ, Med Ctr, Biomed Informat, Nashville, TN USA
[7] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA
[8] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA
[9] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol CAGE, Cincinnati, OH 45229 USA
[10] US Dept Vet Affairs, Med Ctr, Cincinnati, OH USA
[11] Marshfield Clin Res Inst, Off Res Comp & Analyt, Marshfield, WI USA
[12] Marshfield Clin Res Inst, Ctr Precis Med Res, Marshfield, WI USA
关键词
anti-TNF alpha; genome-wide association study; inflammatory bowel disease; primary nonresponse; single-nucleotide polymorphism; GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; ULCERATIVE-COLITIS; INFLIXIMAB; MANIFESTATIONS; POLYMORPHISMS; VARIANTS; DRUG; METAANALYSIS; IMPUTATION;
D O I
10.1097/FPC.0000000000000445
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objectives Primary nonresponse (PNR) to antitumor necrosis factor-alpha (TNF alpha) biologics is a serious concern in patients with inflammatory bowel disease (IBD). We aimed to identify the genetic variants associated with PNR. Patients and methods Patients were recruited from outpatient GI clinics and PNR was determined using both clinical and endoscopic findings. A case-control genome-wide association study was performed in 589 IBD patients and associations were replicated in an independent cohort of 293 patients. Effect of the associated variant on gene expression and TNF alpha secretion was assessed by cell-based assays. Pleiotropic effects were investigated by Phenome-wide association study (PheWAS). Results We identified rs34767465 as associated with PNR to anti-TNF alpha therapy (odds ratio: 2.07, 95% CI, 1.46-2.94, P = 2.43 x 10(-7), [replication odds ratio: 1.8, 95% CI, 1.04-3.16, P = 0.03]). rs34767465 is a multiple-tissue expression quantitative trait loci for FAM114A2. Using RNA-sequencing and protein quantification from HapMap lymphoblastoid cell lines (LCLs), we found a significant decrease in FAM114A2 mRNA and protein expression in both heterozygous and homozygous genotypes when compared to wild type LCLs. TNF alpha secretion was significantly higher in THP-1 cells [differentiated into macrophages] with FAM114A2 knockdown versus controls. Immunoblotting experiments showed that depletion of FAM114A2 impaired autophagy-related pathway genes suggesting autophagy-mediated TNF alpha secretion as a potential mechanism. PheWAS showed rs34767465 was associated with comorbid conditions found in IBD patients (derangement of joints [P = 3.7 x 10(-4)], pigmentary iris degeneration [P = 5.9 x 10(-4)], diverticulum of esophagus [P = 7 x 10(-4)]). Conclusions We identified a variant rs34767465 associated with PNR to anti-TNF alpha biologics, which increases TNF alpha secretion through mechanism related to autophagy. rs34767465 may also explain the comorbidities associated with IBD.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [31] The Influence of Anti-TNF Therapy on the Course of Chronic Hepatitis C Virus Infection in Patients with Inflammatory Bowel Disease
    Ming Valerie Lin
    Wojciech Blonski
    Anna M. Buchner
    K. Rajender Reddy
    Gary R. Lichtenstein
    Digestive Diseases and Sciences, 2013, 58 : 1149 - 1156
  • [32] Therapeutic drug monitoring of anti-TNF therapy in children with inflammatory bowel disease
    van Hoeve, Karen
    Hoffman, Ilse
    Vermeire, Severine
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (02) : 185 - 196
  • [33] Adherence to Anti-TNF Therapy in Inflammatory Bowel Diseases: A Systematic Review
    Lopez, Anthony
    Billioud, Vincent
    Peyrin-Biroulet, Carina
    Peyrin-Biroulet, Laurent
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (07) : 1528 - 1533
  • [34] Serial Tuberculosis Screening in Inflammatory Bowel Disease Patients Receiving Anti-TNFα Therapy
    Abreu, Candida
    Afonso, Joana
    Dias, Claudia Camila
    Ruas, Rogerio
    Sarmento, Antonio
    Magro, Fernando
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (10) : 1223 - 1229
  • [35] Cytomegalovirus, inflammatory bowel disease, and anti-TNFα
    Sara T. Campos
    Francisco A. Portela
    Luís Tomé
    International Journal of Colorectal Disease, 2017, 32 : 645 - 650
  • [36] Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with inflammatory bowel disease
    Eirini Theodoraki
    Eleni Orfanoudaki
    Kalliopi Foteinogiannopoulou
    Nikolaos-Panagiotis Andreou
    Maria Gazouli
    Ioannis E. Koutroubakis
    International Journal of Colorectal Disease, 2022, 37 : 639 - 646
  • [37] Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease
    Santella, Christina
    Bitton, Alain
    Filliter, Christopher
    Bessissow, Talat
    Vutcovici, Maria
    Lakatos, Peter L.
    Brassard, Paul
    INFLAMMATORY BOWEL DISEASES, 2022, 28 (02) : 176 - 182
  • [38] Increased Discontinuation Rates of Anti-TNF Therapy in Elderly Inflammatory Bowel Disease Patients
    de Jong, M. E.
    Smits, L. J. T.
    van Ruijven, B.
    den Broeder, N.
    Russel, M. G. V. M.
    Romkens, T. E. H.
    West, R. L.
    Jansen, J. M.
    Hoentjen, F.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (07) : 888 - 895
  • [39] Changes in T Lymphocytes and Cytokines After Anti-TNF Treatment in Pediatric Inflammatory Bowel Disease: Association with Response to Pharmacologic Therapy
    Zapata-Cobo, Paula
    Salvador-Martin, Sara
    Gil-Manso, Sergio
    Rodriguez-Belvis, Marta Velasco
    Palomino, Laura M.
    Moreno-alvarez, Ana
    Perez-Moneo, Begona
    Garcia-Romero, Ruth
    Fobelo, Maria J.
    Garcia-Tirado, Diana
    Sanchez, Cesar
    Pujol-Muncunill, Gemma
    Segarra, Oscar
    Montraveta, Montserrat
    Magallares, Lorena
    Correa-Rocha, Rafael
    Sanjurjo-Saez, Maria
    Pion, Marjorie
    Lopez-Fernandez, Luis A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (07)
  • [40] Favorable Effect of Anti-TNF Therapy on Insulin Sensitivity in Nonobese, Nondiabetic Patients with Inflammatory Bowel Disease
    Paschou, Stavroula A.
    Kothonas, Fotios
    Lafkas, Apostolos
    Myroforidis, Alexandros
    Loi, Vasiliki
    Terzi, Thomais
    Karagianni, Olympia
    Poulou, Androniki
    Goumas, Konstantinos
    Vryonidou, Andromachi
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2018, 2018